高同型半胱氨酸血症可能是DVT新的不容忽视的危险因素。
Hyperhomocysteinaemia is a new and important risk factor for DVT.
目的：观察以同型半胱氨酸血症为中心对脑血管病综合治疗的效果。
Objective: To observe the comprehensive treatment effect of the cerebrovascular diseases caused by homocysteine.
目的探讨牛磺酸对伴有高同型半胱氨酸血症的脑梗死患者的治疗作用。
Objective To investigate the therapeutic action of Taurine in patients with cerebral infarction induced by hyperhomocysteinemia.
目的：观察B族维生素联合治疗对脑卒中患者高同型半胱氨酸血症的疗效与安全性。
Objective: To study the efficacy and safety of B-group vitamins treatment in the stroke patients with hyperhomocysteinemia.
目的：研究饮食诱导高同型半胱氨酸血症对大鼠颈动脉球囊损伤后新内膜增生的影响。
Objective: To study the effect of diet-induced hyperhomocysteinemia on the intimal hyperplasia in a rat model of carotid artery balloon injury.
结论：高血压、血纤溶系统活性升高、高水平纤维蛋白原、高同型半胱氨酸血症是脑梗死再发的重要危险因素。
Conclusion Hypertension, increased plasma PAI-1 activity, fibrinogen level and plasma Hcy level are the important risk factors in the recurrent cerebral infarction.
结论：高血压、血纤溶系统活性升高、高水平纤维蛋白原、高同型半胱氨酸血症是脑梗死再发的重要危险因素。
Conclusion Hypertension, increased plasma PAI-1 activity, fibrinogen level and plasma Hcy level are the important risk factors in the recurrent cerebral infarction.
应用推荐